Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations

Frontiers in Neurology

Neurology

Ameenah Bibi Mia Sorefan¹  Kusumadewi Suharya (Dy)²  Yves Joanette³  Suzana Shahar⁴  Huali Wang⁵  Adelina Comas-Herrera⁶  Tarun Dua⁷  Neerja Chowdhary⁷  Ruth Stephen⁸  Corrado Barbui⁹  Amit Dias^1,10  Cleusa P. Ferri^1,11  Jenni Kulmala^1,12  Miia Kivipelto^1,13  Kibachio J. Mwangi^1,14  Riadh Gouider^1,15  Martin Prince^1,16  Ronald C. Petersen^1,17  Charles Alessi^1,18  Dorairaj Prabhakaran^1,19  Mariagnese Barbera^2,20  Shanthi Mendis^2,21  Kimberly Ashby-Mitchell^2,22  Ayesha A. Motala^2,23  Kaarin J. Anstey^2,24  Lidan Zheng^2,25  Ruth Peters^2,25 

[1] Alzheimer Association, Quatre Bornes, Mauritius;Alzheimer's Disease International, Jakarta, Indonesia;Canadian Institutes of Health Research, Government of Canada, Ottawa, ON, Canada;Centre for Healthy Aging and Wellness, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia;Dementia Care and Research Center, Peking University Institute of Mental Health, Beijing, China;Beijing Dementia Key Laboratory, Beijing, China;Department of Health Policy, Care Policy and Evaluation Centre, London School of Economics and Political Science, London, United Kingdom;Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland;Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;Department of Neuroscience, Biomedicine and Movement Sciences, WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, University of Verona, Verona, Italy;Department of Preventive and Social Medicine, Goa Medical College, Goa, India;Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil;Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden;Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland;Faculty of Social Sciences (Health Sciences) and Gerontology Research Centre (GEREC), Tampere University, Tampere, Finland;Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden;The Ageing Epidemiology Research Unit, Imperial College London, School of Public Health, London, United Kingdom;Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland;Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden;Division of Non-communicable Diseases, Ministry of Health, Nairobi, Kenya;Faculty of Medicine, Clinical Investigation Centre Neurosciences and Mental Health Razi University Hospital, Tunis, Tunisia;Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia;King's College London, London, United Kingdom;Mayo Clinic, Rochester, MN, United States;Public Health England, London, United Kingdom;Public Health Foundation of India, New Delhi, India;The Ageing Epidemiology Research Unit, Imperial College London, School of Public Health, London, United Kingdom;Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;The Geneva Learning Foundation, Geneva, Switzerland;The Mona Ageing and Wellness Centre, University of the West Indies, Kingston, Jamaica;University of KwaZulu-Natal, Durban, South Africa;University of New South Wales, Sydney, NSW, Australia;University of New South Wales, Sydney, NSW, Australia;Neuroscience Research Australia, Sydney, NSW, Australia;

关键词: dementia;    dementia risk reduction guidelines;    dementia risk reduction trials;    WHO guidelines;    cognitive decline;   

DOI  :  10.3389/fneur.2021.765584

 received in 2021-08-27, accepted in 2021-12-07,  发布年份 2022

来源: Frontiers

【 摘 要 】

With population ageing worldwide, dementia poses one of the greatest global challenges for health and social care in the 21st century. In 2019, around 55 million people were affected by dementia, with the majority living in low- and middle-income countries. Dementia leads to increased costs for governments, communities, families and individuals. Dementia is overwhelming for the family and caregivers of the person with dementia, who are the cornerstone of care and support systems throughout the world. To assist countries in addressing the global burden of dementia, the World Health Organisation (WHO) developed the Global Action Plan on the Public Health Response to Dementia 2017–2025. It proposes actions to be taken by governments, civil society, and other global and regional partners across seven action areas, one of which is dementia risk reduction. This paper is based on WHO Guidelines on risk reduction of cognitive decline and dementia and presents recommendations on evidence-based, multisectoral interventions for reducing dementia risks, considerations for their implementation and policy actions. These global evidence-informed recommendations were developed by WHO, following a rigorous guideline development methodology and involved a panel of academicians and clinicians with multidisciplinary expertise and representing geographical diversity. The recommendations are considered under three broad headings: lifestyle and behaviour interventions, interventions for physical health conditions and specific interventions. By supporting health and social care professionals, particularly by improving their capacity to provide gender and culturally appropriate interventions to the general population, the risk of developing dementia can be potentially reduced, or its progression delayed.

【 授权许可】

Unknown   
Copyright © 2022 Chowdhary, Barbui, Anstey, Kivipelto, Barbera, Peters, Zheng, Kulmala, Stephen, Ferri, Joanette, Wang, Comas-Herrera, Alessi, Suharya (Dy), Mwangi, Petersen, Motala, Mendis, Prabhakaran, Bibi Mia Sorefan, Dias, Gouider, Shahar, Ashby-Mitchell, Prince and Dua.